Boosting Chinese Healthcare Service Providers' Utilization of Smoking Cessation Interventions by 'WeChat WeQuit' Program

NCT03556774 | Unknown DMC

• 1 other identifier: 2017S094
• Study Type: interventional
• Target: 2,200
• Locations: 1 country
• Sites: 1

Brief Summary

In this single-blind, randomized trial, undertaken in China with 8-week interventions and follow-up to 52 weeks, about 2,200 providers will be randomly allocated to the intervention or control group.

Conditions

Smoking Cessation Intervention; Smoking Abstinence

Outcome Measures

Primary Outcomes (1)

• The effectiveness of 'WeChat WeQuit' training program.

  The utilization rate (i.e. rate=smokers treated divided by smokers seen) of behavioral and pharmacotherapy interventions by HSP for smoking patients from 8 to 52-week.

  52 weeks

Secondary Outcomes (1)

• Prevalence of smoking abstinence

  24 weeks

Study Arms (2)

With smoking cessation training

EXPERIMENTAL

Participants who allocate to the intervention group will receive regular smoking cessation training program messages by professional team. One to six messages will be sent per day for 8 weeks. Hand copy of behavioral and pharmacotherapy interventions manual will send to each HSP by mail after randomization. One to three messages will be sent per week until the end of the 1-year follow-up. They will also be encouraged to communicate the experience of using behavioral and pharmacotherapy interventions in their group.

Behavioral: 'WeChat WeQuit' smoking cessation training program

Without smoking cessation training

NO INTERVENTION

Control group participants will not receive any smoking cessation messages by professional team. They will receive messages of thanking them for being in the study and reminding them of the time until 52-week follow-up. One to six messages will be sent per week for 8 weeks. They will be encouraged to communicate the experience of helping patients quit smoking in their group.

Interventions

'WeChat WeQuit' smoking cessation training program BEHAVIORAL

Providing 'WeChat WeQuit' smoking cessation training program for healthcare service providers (HSPs) and assessing their utilization of behavioral and pharmacotherapy interventions for cigarette smoking cessation.

With smoking cessation training

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Chinese-speaking healthcare service providers
• Know how to use WeChat
• Use WeChat on a daily basis
• Willing to provide informed consent to participate in the study -

You may not qualify if:

• Non-Chinese speakers
• Not healthcare service providers
• Do not use WeChat
• Unwilling to participate in the study -

Sponsors & Collaborators

• Sir Run Run Shaw Hospital: lead
• Pfizer: collaborator

Study Sites (1)

Yanhui Liao

Hangzhou, Zhejiang, 310016, China

RECRUITING

Related Publications (1)

• Wang Y, Peng P, Wu Z, Liu Y, Wang C, Tang J, Liao Y. Boosting Smoking Cessation Intervention Utilization in Chinese Health Care Providers: A Randomized Controlled Trial of the "WeChat WeQuit" Medical Education Program. Nicotine Tob Res. 2024 Dec 23;27(1):61-72. doi: 10.1093/ntr/ntae166.

  PMID: 39083005 DERIVED

Central Study Contacts

Yanhui Liao, MD

CONTACT

+8615116225099; tangliaoyanhui@163.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: INVESTIGATOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Attending Psychiatrist

Study Record Dates

• First Submitted: April 29, 2018
• First Posted: June 14, 2018
• Study Start: April 1, 2019
• Primary Completion: August 30, 2021
• Study Completion: August 30, 2021
• Last Updated: August 12, 2020

Record last verified: 2020-08

Locations

CN (1)